Nationwide Fund Advisors’s AMAG Pharmaceuticals, Inc. AMAG Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q4 | – | Sell |
-50,978
| Closed | -$941K | – | 2629 |
|
2017
Q3 | $941K | Sell |
50,978
-1,646
| -3% | -$30.4K | ﹤0.01% | 1831 |
|
2017
Q2 | $968K | Buy |
52,624
+5,800
| +12% | +$107K | ﹤0.01% | 1793 |
|
2017
Q1 | $1.06M | Sell |
46,824
-5,903
| -11% | -$133K | ﹤0.01% | 1718 |
|
2016
Q4 | $1.84M | Sell |
52,727
-2,535
| -5% | -$88.2K | 0.01% | 1441 |
|
2016
Q3 | $1.35M | Sell |
55,262
-3,500
| -6% | -$85.8K | 0.01% | 1601 |
|
2016
Q2 | $1.41M | Buy |
58,762
+36,367
| +162% | +$870K | 0.01% | 1533 |
|
2016
Q1 | $524K | Buy |
22,395
+2,070
| +10% | +$48.4K | ﹤0.01% | 2072 |
|
2015
Q4 | $614K | Sell |
20,325
-176,193
| -90% | -$5.32M | ﹤0.01% | 2003 |
|
2015
Q3 | $7.81M | Buy |
196,518
+82,000
| +72% | +$3.26M | 0.04% | 653 |
|
2015
Q2 | $7.91M | Sell |
114,518
-26,969
| -19% | -$1.86M | 0.03% | 710 |
|
2015
Q1 | $7.73M | Buy |
141,487
+54,260
| +62% | +$2.97M | 0.03% | 747 |
|
2014
Q4 | $3.72M | Buy |
87,227
+68,477
| +365% | +$2.92M | 0.02% | 1094 |
|
2014
Q3 | $598K | Buy |
18,750
+1,683
| +10% | +$53.7K | ﹤0.01% | 2103 |
|
2014
Q2 | $354K | Buy |
17,067
+407
| +2% | +$8.44K | ﹤0.01% | 2458 |
|
2014
Q1 | $322K | Hold |
16,660
| – | – | ﹤0.01% | 2269 |
|
2013
Q4 | $404K | Sell |
16,660
-491
| -3% | -$11.9K | ﹤0.01% | 2337 |
|
2013
Q3 | $368K | Buy |
17,151
+848
| +5% | +$18.2K | ﹤0.01% | 2370 |
|
2013
Q2 | $363K | Buy |
+16,303
| New | +$363K | ﹤0.01% | 2184 |
|